T. D. de Villiers

发表

Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging

P. Sluss, S. Harlow, R. Rebar, 2012, Climacteric : the journal of the International Menopause Society.

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

P. Sluss, S. Harlow, R. Rebar, 2012, The Journal of clinical endocrinology and metabolism.

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging

P. Sluss, S. Harlow, R. Rebar, 2012, Menopause.

Osteoporosis management in hematologic stem cell transplant recipients: Executive summary

R. Rizzoli, P. Ebeling, J. Body, 2021, Journal of bone oncology.

Cardiovascular risk assessment in women – an update

N. Panay, C. Webb, P. Collins, 2016, Climacteric : the journal of the International Menopause Society.

Menopausal hot flushes and night sweats: where are we now?

A. Maclennan, M. Hickey, A. Pines, 2011, Climacteric : the journal of the International Menopause Society.

Risks and benefits of hormone therapy: has medical dogma now been overturned?

S. Shapiro, H. Burger, A. Pines, 2014, Climacteric : the journal of the International Menopause Society.

Effects of ospemifene on bone in postmenopausal women

T. D. de Villiers, M. Gambacciani, C. Altomare, 2019, Climacteric : the journal of the International Menopause Society.

8th Pieter van Keep Memorial Lecture Estrogen and bone: have we completed a full circle?

T. D. de Villiers, 2014, Climacteric : the journal of the International Menopause Society.

The WHI: the effect of hormone replacement therapy on fracture prevention

T. D. de Villiers, J. Stevenson, 2012, Climacteric : the journal of the International Menopause Society.

Menopause redefined

T. D. de Villiers, D. Sturdee, 2011, Climacteric : the journal of the International Menopause Society.

Medical Management of Endometriosis, Present and Future with Special Reference to MHT in the Patient Previously Diagnosed with Endometriosis

T. D. de Villiers, T. J. Villiers, 2020 .

Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms

N. Panay, W. Bao, P. Vincendon, 2012, Climacteric : the journal of the International Menopause Society.

Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.

A. Chines, T. D. de Villiers, S. Mirkin, 2013, Maturitas.

Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis

T. D. de Villiers, 2010, Climacteric : the journal of the International Menopause Society.

Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1–34) in the treatment of osteoporosis

T. D. de Villiers, S. Lipschitz, G. Ellis, 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Revised Global Consensus Statement on Menopausal Hormone Therapy

M. Rees, D. Pierroz, T. D. de Villiers, 2016, Climacteric : the journal of the International Menopause Society.

Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone

R. Tuimala, N. Siseles, T. D. de Villiers, 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Revised global consensus statement on menopausal hormone therapy.

M. Rees, D. Pierroz, T. D. de Villiers, 2016, Maturitas.

The role of menopausal hormone therapy in osteoporosis

T. D. de Villiers, 2007, Climacteric : the journal of the International Menopause Society.

Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women

T. D. de Villiers, 2009, Climacteric : the journal of the International Menopause Society.

Global Consensus Statement on menopausal hormone therapy.

R. Lobo, M. Rees, D. Pierroz, 2013, Maturitas.

Global Consensus Statement on Menopausal Hormone Therapy

R. Lobo, M. Rees, D. Pierroz, 2013, Climacteric : the journal of the International Menopause Society.

Individualized therapy for osteoporosis prevention and treatment in women under 60

T. D. de Villiers, 2009, Climacteric : the journal of the International Menopause Society.

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy

C. Castelo-Branco, J. Simon, R. Nappi, 2015, Climacteric : the journal of the International Menopause Society.

Neonatal pancreatic function in infants born to mothers with gestational and overt diabetes.

T. D. de Villiers, N. Tsakalakos, J. Taljaard, 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Current knowledge of the effect of tibolone on the breast and uterus: an extract from the guidelines for the use of tibolone in South Africa

T. D. de Villiers, F. Guidozzi, J. Coetzee, 2010 .

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Sherry Sherman, Patrick M Sluss, Siobán D Harlow, 2012, Fertility and sterility.

Prevention of diseases after menopause

S. Shapiro, V. Henderson, W. Mack, 2014, Climacteric : the journal of the International Menopause Society.

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

R. Langer, V. Henderson, S. Davis, 2013, Climacteric : the journal of the International Menopause Society.

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy

C. Castelo-Branco, N. Panay, J. Simon, 2014, Climacteric : the journal of the International Menopause Society.

The quest for new drugs to prevent osteoporosis-related fractures

T. D. de Villiers, 2017, Climacteric : the journal of the International Menopause Society.

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

Claus Christiansen, Harry K Genant, C. Christiansen, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

HRT in the early menopause: scientific evidence and common perceptions

F. Naftolin, A. Pines, H. Hodis, 2008, Climacteric : the journal of the International Menopause Society.

NOFSA Guideline for the Diagnosis and Management of Osteoporosis

J. Pettifor, T. D. de Villiers, B. Cassim, 2010 .

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture

Jacques P. Brown, S. Silverman, A. Chines, 2015, Menopause.

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

C. Cooper, J. Reginster, R. Rizzoli, 2017, Journal of bone oncology.

South African Menopause Society revised consensus position statement on menopausal hormone therapy, 2014.

P. Roos, T. D. de Villiers, F. Guidozzi, 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Oncology in midlife and beyond

S. Shapiro, R. Santen, A. Gompel, 2013, Climacteric : the journal of the International Menopause Society.

Should women be screened for osteoporosis at midlife?

T. D. de Villiers, 2018, Climacteric : the journal of the International Menopause Society.

Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis

A. Santora, A. Pong, B. Langdahl, 2021, Osteoporosis International.

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

A. Chines, G. Constantine, D. Archer, 2009, Menopause.

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

H. Burger, T. Maudelonde, A. Genazzani, 2004, Climacteric : the journal of the International Menopause Society.

The role of menopausal hormone therapy in osteoporosis

T. D. de Villiers, T. D. Villiers, 2007, Climacteric : the journal of the International Menopause Society.

Improved management of patients with osteoporosis.

J. Pettifor, T. D. de Villiers, B. Cassim, 2012, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Bone health and menopause: Osteoporosis prevention and treatment.

T. D. de Villiers, 2023, Best practice & research. Clinical endocrinology & metabolism.

HRT in the early menopause: scientific evidence and common perceptions

F. Naftolin, A. Pines, H. Hodis, 2008, Climacteric : the journal of the International Menopause Society.

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture

Jacques P. Brown, S. Silverman, A. Chines, 2015, Menopause.